510(k) K030702

IMMULISA ANTI-BETA2 GLYCOPROTEIN I (B2GP1) IGM ELISA by Immco Diagnostics, Inc. — Product Code MSV

K030702 is an FDA 510(k) premarket notification submitted by Immco Diagnostics, Inc. for the device "IMMULISA ANTI-BETA2 GLYCOPROTEIN I (B2GP1) IGM ELISA". The FDA issued a decision of Substantially Equivalent on September 9, 2003. The device falls under product code MSV (System,Test,Antibodies,B2 - Glycoprotein I (B2 - Gpi)), a Class II device regulated under 21 CFR 866.5660. Immco Diagnostics, Inc. has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
September 9, 2003
Date Received
March 6, 2003
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
System,Test,Antibodies,B2 - Glycoprotein I (B2 - Gpi)
Device Class
Class II
Regulation Number
866.5660
Review Panel
IM
Submission Type